Molecular and pathological profiling of corresponding treatment-naïve and neoadjuvant pazopanib-treated high-risk soft tissue sarcoma samples of the GISG-04/NOPASS study
BRAF V600E; CDK4; MAP2K1 E203K; NGS; STS; next generation sequencing; pazopanib; soft tissue sarcoma
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
9 July 2021
|
| In: |
Biology
Year: 2021, Volume: 10, Issue: 7, Pages: 1-9 |
| ISSN: | 2079-7737 |
| DOI: | 10.3390/biology10070639 |
| Online Access: | Resolving-System, kostenfrei: https://dx.doi.org/10.3390/biology10070639 |
| Author Notes: | Timo Gaiser, Christian Sauer, Alexander Marx, Jens Jakob, Bernd Kasper, Peter Hohenberger, Daniela Hirsch and Ulrich Ronellenfitsch |
| Summary: | BRAF V600E; CDK4; MAP2K1 E203K; NGS; STS; next generation sequencing; pazopanib; soft tissue sarcoma |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 2079-7737 |
| DOI: | 10.3390/biology10070639 |